Rubicon Research Limited is conducting walk-in interviews for its Technology Transfer team at Pithampur, Madhya Pradesh. The openings are for Officer / Senior Officer and Executive roles in Technology Transfer/ MSAT solid oral dosage (OSD). These are positions are exclusively open for B Pharm/ M Pharm candidates with 2 – 8 years of relevant experience. The work involves supporting scale-up, reviewing technical documents, and helping establish consistent manufacturing processes.
Rubicon ReseResearch Recruitment Overview – 2026
| Parameter | Details |
|---|---|
| Company | Rubicon Research Limited |
| Department | Technology Transfer / MSAT |
| Dosage Form | Solid Orals (OSD) |
| Positions | Officer / Senior Officer – Technology Transfer; Executive – Technology Transfer |
| Qualification | B.Pharm / M.Pharm (Pharmaceutics preferred) |
| Experience | Officer / Senior Officer: 2–5 years Executive: 5–8 years |
| Interview Date | 19 November 2026 |
| Interview Time | 10:00 AM to 3:00 PM |
| Venue | Rubicon Research Limited, A-17, Phase 2, SEZ, Pithampur, District Dhar, Madhya Pradesh – 454775 |
Available Positions and Eligibility
Officer / Senior Officer – Technology Transfer
Candidates should have a B.Pharm or M.Pharm qualification and 2 to 5 years of relevant experience. A background in Pharmaceutics is preferred. The opening is for solid oral dosage products.
Executive – Technology Transfer
For the Executive position, the company is seeking B.Pharm or M.Pharm candidates with 5 to 8 years of relevant experience. Pharmaceutics is the preferred specialisation, with exposure to solid oral dosage manufacturing.
Key Responsibilities
- Prepare and review technology transfer documents, protocols, checklists, and manufacturing instructions.
- Coordinate SAMMED documentation for scale-up, exhibit, and validation batches.
- Ensure the transfer of critical process parameters (CPPs), critical quality attributes (CQAs), and process controls from development to commercial scale.
- Perform scale-up calculations and monitor scale-up, exhibit, and validation batch execution.
- Evaluate batch data, yields, and machine performance.
- Collaborate with R&D, F&D, Production, QA, QC, Warehouse, and Engineering teams.
- Handle QMS workflows, including change controls, deviations, risk assessments, and CAPAs.
- Support regulatory audits, including USFDA and MHRA audits, with technical data.
Required Skills and Exposure
Applicants should understand the main unit operations used in OSD manufacturing, including wet and dry granulation, blending, compression, coating, and capsulation.
- Proficiency in scale-up calculations, process yields, and equipment capacities.
- Knowledge of quality management systems, change control, deviation management, and quality risk management.
- Ability to compile validation protocols, reports, and summary reports.
- Good communication and coordination skills across departments.
- Readiness to work in rotational shifts.
- Familiarity with SAMMED or other pharma ERP systems is preferred.
Walk-In Interview Details
Date of interview: 19th November 2026
Time: 10:00 AM to 3:00 PM
Venue:
Rubicon Research Limited
A-17, Phase 2, SEZ, Pithampur
District Dhar, Madhya Pradesh – 454775.

About Rubiocn Research Limited
Rubicon Research Pvt. Ltd., now Rubicon Research Limited, is a Mumbai-based, R&D-driven pharmaceutical formulations company founded in 1999. Started as a contract formulation development provider, the company operationalized its oral-solids manufacturing facility at Ambernath, Maharashtra in 2011 and since 2012 has focused on developing, manufacturing and commercializing its own branded specialty and generic prescription products, predominantly for the highly regulated US market. With its principal R&D centre in Thane, India and a development centre for inhalation and nasal products in Ontario, Canada, and two USFDA-inspected, cGMP-compliant manufacturing facilities in Maharashtra, Rubicon has a portfolio of 55+ commercialized products in the US across 69 active NDAs and ANDAs – including oral capsules, tablets, liquids, suspensions and syrups, ophthalmic drops, delayed and extended-release tablets, and drug-device combinations like nasal sprays.
